

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 400mg | 180 pills | €1.81 | €362.53 €326.28 Best Price Popular | |
| 400mg | 120 pills | €1.94 | €258.04 €232.24 | |
| 400mg | 90 pills | €2.08 | €207.38 €186.64 | |
| 400mg | 60 pills | €2.24 | €148.80 €133.92 | |
| 400mg | 30 pills | €2.49 | €83.89 €75.50 |
Why does ulcerative colitis flare with abdominal cramps, urgency, and occasional blood in the stool, and could a single medicine help calm the damaged lining of the colon? Asacol is a prescription medicine designed to reduce inflammation in the colon, which is the part of the gut affected by ulcerative colitis. It belongs to the class of drugs known as 5-aminosalicylic acids, or 5-ASAs, and works locally where it is needed. The active ingredient is mesalamine, the portion of the drug that acts directly on the colon lining.
Asacol is formulated to release mesalamine in the large intestine rather than in the stomach. This targeted delivery aims to limit systemic exposure and concentrate anti-inflammatory effects where the disease causes symptoms. In practical terms, the medicine is designed to help bring down inflammation, reduce abdominal pain, and improve stool consistency and frequency for many patients with ulcerative colitis.
In Ireland, Asacol may require a prescription depending on local rules. The standard information leaflet explains how the product should be stored, how to take it, and what to discuss with a pharmacist or clinician before starting treatment. Understanding the basic purpose of the medicine can help you follow instructions and recognise when to seek guidance from a clinician.
Asacol is generally used as part of a broader treatment plan. This can include diet changes, regular monitoring, and other medications as directed by a clinician. It is not a cure, but a therapy aimed at controlling symptoms and reducing inflammation in the colon over time.
Ulcerative colitis is a chronic inflammatory condition of the colon. It commonly presents with periods of increased symptoms followed by times of relative stability. The primary goal of Asacol is to help manage active inflammation and support a return toward remission, where symptoms are milder or absent.
Asacol is used to treat mild to moderate ulcerative colitis, particularly when inflammation is limited to the colon. It may also be considered for maintenance in certain cases, depending on the formulation and doctor’s advice. The medicine targets the inflamed lining to reduce irritation and bleeding associated with the disease.
People with ulcerative colitis may experience symptoms such as abdominal cramps, loose stools, urgency, and blood in the stool. While these symptoms can fluctuate, the goal of therapy is to reduce their frequency and severity. Always discuss symptom changes with a clinician, especially if new symptoms arise or existing ones worsen.
Other indications and language in patient information leaflets may cover specific disease patterns. If you have extraintestinal manifestations or questions about whether Asacol is suitable for a particular presentation of inflammatory bowel disease, consult a healthcare professional for personalised guidance.
Mesalamine acts primarily on the inner lining of the colon. It reduces the inflammatory signals that drive swelling and irritation in ulcerative colitis. By dampening these signals, the mucosa becomes calmer, and the chain of symptoms tied to inflammation slows down.
The medication is designed to act locally in the colon rather than circulating widely in the body. This local action aims to lower systemic exposure and minimise the risk of widespread side effects. In simple terms, Asacol delivers help where it is needed most: the inflamed colon lining.
Researchers describe the anti-inflammatory effect in practical terms as a reduction in the production of certain inflammatory substances. With less irritation in the colon, patients may notice improvements in stool consistency, urgency, and abdominal discomfort over time, though responses vary from person to person.
As with many medicines, the exact degree of response depends on factors such as disease extent, duration, and individual tissue sensitivity. For some, the benefit becomes evident after several weeks of consistent use; for others, it may take longer or be complemented by other therapies as advised by a clinician.
Take Asacol exactly as prescribed by your clinician and as described in the official patient information leaflet. The way you take it can depend on the specific product you have, including the release profile and the instructions given at the time of dispensing. Do not change the dose or schedule without medical advice.
Generally, tablets are swallowed whole with a full glass of water. Do not crush, chew, or break tablets unless your prescriber or pharmacist specifically instructs you to do so. Crushing or breaking certain formulations can alter where the drug is released in the gut, which can affect effectiveness and safety.
Timing can be important for some formulations. Some products are intended to be taken with meals, while others are designed to be taken on an empty stomach. Your pharmacist or clinician will provide guidance tailored to the exact Asacol product you are using. If you miss a dose, contact your clinician for instructions rather than doubling up without advice.
Storage should follow the packaging directions. Keep medicines out of reach of children, and protect from moisture and heat as advised. If you have trouble swallowing tablets, speak to your pharmacist about suitable alternatives or formulations that may be easier to take. Always refer to the official leaflet for any storage specifics relevant to your product.
Contraindications identify situations where a medicine should not be used because it could cause harm. People who have a known allergy to mesalamine or any ingredients in the product should not take Asacol. Allergic reactions can vary in severity and may include rash, swelling, or difficulty breathing, and require urgent medical attention.
Severe kidney problems can affect how mesalamine is processed in the body and may necessitate alternatives or close monitoring. If you have reduced kidney function or a history of kidney issues, discuss this with a clinician before starting treatment. The clinician may adjust therapy or recommend regular kidney tests during treatment.
Discuss with your doctor if you have liver disease, a history of pancreatitis, or a significant intestinal obstruction. These conditions can influence safety or how well the medicine works. Do not start Asacol if you are pregnant or breastfeeding without discussing it with a healthcare professional, unless the clinician has advised it as appropriate for you.
In all cases, inform your healthcare team about any other medicines you take, including over‑the‑counter drugs, herbal products, or supplements. Some combinations may not be suitable or require monitoring. If in doubt, check the official leaflet or ask a pharmacist for clarification before starting the medicine.
As with many anti-inflammatory medicines, monitoring is important. If you develop signs of dehydration, persistent abdominal pain, fever, or new blood in stools, contact a clinician promptly. These could indicate a complication or a flare in your condition that needs assessment.
Kidney and liver function can be affected by 5-ASA medicines in rare cases. Regular blood tests may be recommended by your doctor to ensure safe use, especially if you have underlying kidney or liver concerns or take other medicines that influence these organs.
If you have a history of allergic reactions to salicylates or other anti-inflammatory drugs, disclose this to your healthcare team. In the event of a severe allergic reaction, seek urgent medical help. Tell all your clinicians about your Asacol use if you are admitted to hospital for any reason.
Inform your clinician if you are planning vaccination, especially with live vaccines. Some vaccines can interact with medications that modulate the immune system or the gut lining, and your doctor can provide tailored guidance. This is a general caution; follow the advice given by your healthcare providers.
Most people tolerate Asacol well, but side effects can occur. Common, usually mild effects include headaches, nausea, abdominal discomfort, and occasional diarrhoea or gas. These often lessen as your body adjusts to the medicine.
Less commonly, people may notice changes in liver enzymes, a feeling of tiredness, or skin reactions such as rashes. If a rash, itching, swelling, or trouble breathing develops, seek medical help promptly. Your clinician may adjust treatment or stop the medicine if needed.
Very rarely, more serious reactions can occur, including signs of kidney problems, severe stomach pain, or unusual bleeding or bruising. If you experience any of these symptoms, contact a healthcare professional without delay. Always report new or concerning symptoms to your pharmacist or doctor so they can assess whether continuation is appropriate.
Not every side effect needs medical intervention, but you should discuss anything unusual or persistent with a clinician. This is part of safe, personalised care, and helps ensure your treatment plan remains appropriate for you.
Tell your pharmacist about all medicines you take, including over‑the‑counter drugs and supplements. Some medicines can interact with Asacol and affect how well it works or increase the risk of side effects. Do not start new medicines without checking first with a clinician.
Concomitant use of other 5-ASA products or certain anti-inflammatory medicines may influence safety or effectiveness. Your clinician may adjust therapy if you are taking multiple anti-inflammatory agents. Food generally does not cause harmful interactions, but your clinician can offer practical guidance based on your overall treatment plan.
Some supplements, particularly those that affect the gut or immune system, may interact indirectly with Asacol. If you are considering herbs or vitamins, discuss this with your pharmacist or physician. They can help you assess potential risks and benefits.
If you receive vaccines, especially live vaccines, discuss timing with your healthcare team. They can advise on scheduling and any necessary precautions while you are on treatment.
Pregnancy and breastfeeding require careful consideration of any medication. Mesalamine-based therapies have been used during pregnancy when clinically needed, but each case should be discussed with a clinician. The potential benefits to the mother must be weighed against any potential risks to the fetus.
Breastfeeding may be compatible with Asacol in some situations, as only small amounts pass into breast milk. Your clinician can help determine the safest approach for you and your baby. Do not start or stop therapy during pregnancy or breastfeeding without medical advice.
In Ireland and elsewhere, pregnancy planning should involve a discussion with obstetric and gastroenterology specialists. If you discover you are pregnant while taking Asacol, contact your healthcare team promptly for guidance on whether to continue, adjust, or pause treatment.
As a general rule, never change medication regimens during pregnancy or breastfeeding without professional supervision. The official leaflets provide more detail on the available data and should be reviewed with your clinician.
Many patients notice improvements within several weeks, but the timeline can vary. Some may feel better sooner, while others require a longer period of consistent use. If symptoms persist or worsen after a defined period, consult your clinician for a reassessment.
If you miss a dose, take it as soon as you remember, unless it is near the time for your next dose. Do not double up to make up for a missed dose. If you are unsure, contact your pharmacist or clinician for guidance specific to your regimen.
Whether to take with food depends on the exact product form. Some formulations are advised to be taken with meals to reduce stomach upset, while others may be taken without regard to meals. Follow the instructions on your leaflet or given by your clinician.
The duration of treatment depends on disease activity and the doctor’s plan. Some patients use Asacol for induction of remission, while others continue for maintenance. Do not stop treatment abruptly without consulting a clinician, as this could affect disease control.
Seek urgent medical advice if you experience signs of severe allergic reaction, persistent severe stomach pain, blood in the stool, high fever, or significant changes in urine or stool color. If you notice new or worsening symptoms or dehydration, contact a clinician promptly.
Long-term safety should be discussed with your clinician. In some cases, ongoing therapy is necessary to prevent flare-ups, but long-term use requires regular review of the balance between benefits and risks, including kidney and liver monitoring as advised.
No. Stopping suddenly can allow inflammation to return or worsen. If you feel well and your clinician is considering stopping therapy, they will guide you through a safe tapering process or an alternative plan.
Report unusual or persistent side effects to your healthcare team. They can determine whether the reaction is related to Asacol and whether a dose adjustment or alternative therapy is appropriate.
There are no universal dietary prohibitions, but some people find that heavy, spicy, or fatty meals can aggravate symptoms during a flare. A clinician or dietitian can provide tailored dietary advice aligned with your treatment plan.
Store Asacol in its original packaging, away from moisture and heat. Keep it out of reach of children. Check the leaflet for any specific storage conditions and discard any tablets that appear damaged or past their expiry date.
Always tell your clinician about all medicines you take, including those for other conditions. Some drug combinations require monitoring or adjustments. Your pharmacist can help you review potential interactions before you start or continue treatment.
The official patient information leaflet that accompanies Asacol provides detailed guidance on dosage, administration, warnings, and side effects. Review this document carefully and keep it with your medication for reference. If anything is unclear, ask your pharmacist to go through it with you so you understand the key points.
Your GP, gastroenterologist, or other healthcare providers can tailor guidance to your situation. They can explain how Asacol fits into your overall treatment plan, monitor your response, and adjust therapy if needed. Do not hesitate to seek their advice if your symptoms change or if you have questions about long-term management.
In Ireland, access to medication information and support is available through local health services and hospital clinics. If you have a concern about interactions, pregnancy planning, or ongoing therapy, your pharmacist is a valuable resource for clarification and practical tips for taking the medicine safely.
For reliable information beyond the product leaflet, consult your healthcare team. They can help interpret any questions you have about your condition, treatment goals, and what to expect during a course of therapy with Asacol. Always prioritise personalised clinical advice over general guidance.
14–21 days. Free from €171.67 .
5–9 days. €25.75
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
